This bill allows Americans to legally import prescription drugs from Canada, the United Kingdom, European Union countries, and Switzerland to address high drug prices in the U.S., which average nearly three times higher than in other developed nations. The legislation permits wholesale distributors, pharmacies, and individuals to import qualifying drugs that are approved and sold in these foreign countries, as long as they have the same active ingredients, strength, and route of administration as FDA-approved versions. The bill requires the FDA to establish regulations and certify foreign pharmacies and distributors within one year of enactment, and it prohibits drug manufacturers from charging higher prices to foreign sellers or restricting their supply to prevent importation. The legislation includes safety measures such as random drug testing, reporting requirements, and the ability to suspend imports if counterfeit or recalled drugs are detected. The law also directs the Department of Health and Human Services to report to Congress within one year on importation activities and every two years thereafter, while the Government Accountability Office must submit a separate report within 18 months analyzing the program's implementation and its effects on drug safety and costs.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.